drugset / Trial / NCT04773093

Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery

NCT04773093

Phase 1/2 Unknown 50 enrolled Indonesia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aimed to compare continous intravenous lidocaine infusion and placebo on the effect to brain relaxation, opioid consumption and postoperative cognitive status in adult patient undergoing craniotomy tumor removal surgery

Timeline

Start
2021-01-01
Primary completion
2021-12-31
Completion
2021-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.